Back to search

Article

Oral Administration Sericin-Curcumin Nanoconjugates Inhibits Inflammation and Epithelial-Mesenchymal Transition to Treat Renal Interstitial Fibrosis

2022-12-14

Abstract excerpt

<h4>Background: </h4> Chronic kidney disease (CKD) is the most common renal disease. Renal interstitial fibrosis (RIF) is an important marker of the progression of chronic kidney disease. Epithelial-interstitial transformation (EMT) and the release of inflammatory factors are the core mechanisms underlying RIF. <h4>Results: </h4>: A type of orally administered nanoconjugate composed of curcumin and sericin was su...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7ec05de7-1238-549a-878e-fae6486e2260
DOI
10.21203/rs.3.rs-2360595/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Oral Administration Sericin-Curcumin Nanoconjugates Inhibits Inflammation and Epithelial-Mesenchymal Transition to Treat Renal Interstitial FibrosisDOI 10.21203/rs.3.rs-2360595/v1
Select a neighboring publication to make it the new centre.